Pharmacy World and Science

, Volume 18, Issue 6, pp 193–194 | Cite as

Saliva as a specimen for therapeutic drug monitoring in pharmacies

  • J. Zuidema
  • K. M. Höld
  • D. de Boer
  • R. A. A. Maes


  1. 1.
    Höld KM. Evaluation of non-invasive techniques in bioanalysis and toxicology. Thesis, Faculty of Pharmacy, Utrecht University, 1996.Google Scholar
  2. 2.
    OnyejiCO, OgunbonaFA. Time-dependent variability of chloroquine secretion into human saliva. Pharmacy World & Science 18(6); 1996;211–16.Google Scholar
  3. 3.
    HöldKM, BoerDde, ZuidemaJ, MaesRAA. Evaluation of the Salivette β as sampling device for monitoring β-adrenoceptor blocking drugs in saliva. J Chromatogr Biomed Appl 663; 1995:103–10.Google Scholar
  4. 4.
    Leufkens HG, Urquhart J. From Strom B (Ed), Pharmaco-epidemiology, sec ed: Pharmaco-epidemiology in the Netherlands, J Wiley & Sons 1994.Google Scholar
  5. 5.
    DeVaneLC, GraselaTH, AntalEJ, MillerRL. Evaluation of population pharmacokinetics in therapeutic trials. IV Application to post marketing surveillance. Clin Pharm Ther 1993;53:521–8.Google Scholar
  6. 6.
    ZuidemaJ and GinnekenCAMvan. Clearance concept in salivary drug excretion. Pharm Acta Helv 1983;58:88–93 and 136–43.Google Scholar
  7. 7.
    DanhofM, BreimerDD. Therapeutic drug monitoring in saliva. Clin Pharmacokin 1978;30:813–4.Google Scholar
  8. 8.
    HöldKM, BoerDde, ZuidemaJ, MaesRAA. Saliva as an analytical tool in toxicology. Int J Drug Testing 1; 1996:1–31.Google Scholar
  9. 9.
    Höld KM, Boer D de, Zuidema J, Maes RAA. Interpretation of saliva concentrations of β-blocking drugs: implications for therapeutic drug monitoring. (Chapter 6 in ref 1 and submitted for publication).Google Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • J. Zuidema
    • 1
  • K. M. Höld
    • 1
  • D. de Boer
    • 1
  • R. A. A. Maes
    • 1
  1. 1.Department of PharmaceuticsFaculty of PharmacyUtrechtThe Netherlands

Personalised recommendations